SCHEMBL20535753

SCHEMBL20535753

CCOC(=O)C(=Cc1ccc(Cl)cc1Oc1ccccc1)N=[N+]=[N-]

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 5/20 0.38
▸ LMNA P02545 4/20 0.38
▸ MAPT P10636 3/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ POLB P06746 2/20 0.37
▸ PLIN1 O60240 1/20 0.37
▸ PLIN5 Q00G26 1/20 0.37
▸ ABHD5 Q8WTS1 1/20 0.37
▸ ATM Q13315 1/20 0.35
▸ HTT P42858 2/20 0.35
▸ TSPO P30536 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20535751 1.00 L3MBTL1 (0.38) L3MBTL1LMNAMAPTSMN1; SMN2TDP1
SCHEMBL20536123 0.89 L3MBTL1 (0.39) L3MBTL1LMNAMAPTSMN1; SMN2MEN1
SCHEMBL20536125 0.89 L3MBTL1 (0.39) L3MBTL1LMNAMAPTSMN1; SMN2MEN1
SCHEMBL23709945 0.81 LMNA (0.41) L3MBTL1LMNAMAPTMEN1KMT2A
SCHEMBL28463731 0.81 GAA (0.38) L3MBTL1LMNAMAPTSMN1; SMN2TDP1
SCHEMBL20536109 0.79 SCN9A (0.37) LMNAMAPTMEN1KMT2APOLB
SCHEMBL20536401 0.79 MAPT (0.41) L3MBTL1LMNAMAPTSMN1; SMN2MEN1
SCHEMBL20536399 0.79 MAPT (0.41) L3MBTL1LMNAMAPTSMN1; SMN2MEN1
SCHEMBL22080767 0.78 GAA (0.38) LMNAMAPTSMN1; SMN2TDP1GAA
SCHEMBL22042074 0.78 GAA (0.38) LMNAMAPTSMN1; SMN2TDP1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018191146-A1 HETEROARYL RHEB INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-10-18 — — WO disclosed
Send feedback